New ketone drink may treat obesity, diabetes and Alzheimer's
- Excessive rains wreak havoc in several states, 81 die due to flood
- Govt, Congress in war of words ahead of all-party meet
- Malaysia seeks help in finding more possible MH370 debris
- Sushma Swaraj has committed no crime: Parrikar on Lalit Modi case
- Congress hits back at Mahesh Sharma over his 'no work, no pay' remark
A new ketone drink could not only help you lose weight, but also treat epilepsy, diabetes and even Alzheimer's, scientists claim.
Researchers have found that the drink might also be an incredible energy booster.
The drink has been developed by Kieran Clarke, professor of physiological biochemistry at Oxford University and head of its Cardiac Metabolism Research Group, at the behest of the US Army, the 'Daily Mail' reported.
The drink contains ketones the tiny, but powerful sources of energy our bodies make naturally when we start using up our fat stores for energy because there are no carbs around.
Clarke found a way to make ketones in the lab. This means that instead of having to follow difficult diets (with unpleasant side-effects such as constipation and bad breath), you can just add ketones to a normal diet ¿ in the form of the Drink, as it's known.
It's a radical new approach, which flies in the face of more than 30 years of advice that a low-fat diet with lots of carbohydrates is the best way to lose weight, treat diabetes and protect your heart.
In an earlier study, Clarke found that rats given the new ketone compound ate less and put on less weight than those getting the same amount of calories from a high-fat or a high-carbohydrate diet.
In the first trial, Clarke has run on humans with diabetes, completed within the past few months, the effects were also impressive. In the week-long study, eight people with diabetes had three ketone drinks a day as well as their normal diet.
The drink has its roots in ketogenic diets, which are designed to raise ketone production. One medical area where a very high-fat ketogenic diet is used as standard treatment is in childhood epilepsy, the report said.